PBE vs. PCIG ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Polen Capital International Growth ETF (PCIG)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$68.56
Average Daily Volume
6,451
30
PCIG
Polen Capital International Growth ETF
PCIG Description
PCIG aims to deliver sustainable, above-average earnings growth and long-term stock price appreciation within the global ex-US equity market. The strategy is rooted in fundamental research, selecting 25-35 large-cap growth companies with a sustainable edge like consistent earnings growth, robust balance sheets, and shareholder-oriented management teams. Such companies are selected within industries characterized by high barriers to entry, such as those requiring substantial capital investment, government approvals, or significant intellectual property. Moreover, it integrates ESG factors into the investment process. While the fund may concentrate investments in the consumer discretionary and financial sectors, it avoids over-concentration in any one industry. Investments are typically held for the long term but are subject to period review and potential sale based on changing market conditions, company performance, or perceived threats to competitive advantage.Grade (RS Rating)
Last Trade
$9.46
Average Daily Volume
5,619
10
Performance
| Period | PBE | PCIG |
|---|---|---|
| 30 Days | 0.09% | -2.52% |
| 60 Days | -3.92% | -4.25% |
| 90 Days | -3.91% | -4.83% |
| 12 Months | 20.96% |
0 Overlapping Holdings
| Symbol | Grade | Weight in PBE | Weight in PCIG | Overlap |
|---|
PBE Overweight 30 Positions Relative to PCIG
| Symbol | Grade | Weight | |
|---|---|---|---|
| UTHR | C | 5.74% | |
| ILMN | C | 5.64% | |
| ALNY | D | 4.78% | |
| AMGN | F | 4.7% | |
| BIIB | F | 4.21% | |
| NBIX | C | 4.18% | |
| XNCR | B | 3.88% | |
| EXEL | B | 3.86% | |
| TGTX | B | 3.78% | |
| BMRN | F | 3.76% | |
| MNKD | C | 3.7% | |
| NTRA | A | 3.56% | |
| REGN | F | 3.38% | |
| INCY | C | 3.35% | |
| VCYT | B | 3.28% | |
| ACAD | C | 3.06% | |
| CPRX | C | 3.0% | |
| BPMC | B | 2.91% | |
| TECH | F | 2.89% | |
| VCEL | B | 2.79% | |
| OPK | C | 2.78% | |
| RGEN | D | 2.76% | |
| PTGX | D | 2.75% | |
| QGEN | D | 2.59% | |
| BCRX | D | 2.56% | |
| HALO | F | 2.42% | |
| COLL | F | 2.27% | |
| CDNA | D | 1.92% | |
| NVAX | F | 1.83% | |
| MYGN | F | 1.61% |
PBE: Top Represented Industries & Keywords
PCIG: Top Represented Industries & Keywords
Compare ETFs
